The TERT oncogenic variants presented in the promotor regions: two cases at c.-124C > T, one case at c.-57A > C, and one case at c.-146C > T; all six BC samples had the HRAS oncogenic variants (either c.34G > A, p.G12S or c.37G > T, p.G13C). Here, HRAS is linked to breast cancer.